Mylan is a global pharmaceutical company, which develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals. It operates in two segments: Generics and Specialty. The company manufactures and sells a portfolio of injectable products across various therapeutic areas. Mylan markets its products to wholesalers, distributors, retail pharmacy chains, group purchasing organizations, government entities, independent pharmacies, managed care organizations, hospitals, nursing homes, and pharmacy benefit managers. Mylan combined with Upjohn to form Viatris, a new healthcare company.